Medicamen Organics IPO Details: Medicamen Organics has announced the date for its upcoming IPO, which will commence on June 21 and conclude on June 25. This IPO, listed on NSE SME, aims to raise ₹10.54 crores. The price band for Medicamen Organics IPO is set at ₹32 to ₹34 per share, with a market lot of 4000 shares.
Medicamen Organics Limited specializes in the development, manufacturing, and distribution of a diverse range of pharmaceutical products, including generic formulations such as Tablets, Capsules, Oral Liquids, Ointments, Gels, Syrups, Suspensions, and Dry powders. The company serves both government (state and central) and private institutions as a contract manufacturer and third-party supplier. Its products are marketed domestically and internationally through third-party distributors and under loan license agreements. Notably, the company has initiated direct exports to Burundi in fiscal 2023, underscoring its strategic international expansion efforts.
Operating primarily on a business-to-business (B2B) model, Medicamen Organics leverages its two WHO GMP-approved manufacturing facilities located at Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar, Uttarakhand. These facilities, spanning 21,536 sq. ft., are equipped with advanced infrastructure and a dedicated quality control department staffed by experienced professionals. The company is ISO 9001:2015 certified and maintains rigorous quality standards through in-house testing of raw materials and finished products.
Medicamen Organics’ core strengths lie in its robust product development capabilities, continuously engaged in research and development to introduce new pharmaceutical offerings. With a portfolio of 84 products covering therapeutic categories like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Proton Pump Inhibitors, Anti-Histamines, and others, the company enjoys a competitive edge in the market.
Focused on consistent quality and safety standards, Medicamen Organics is committed to expanding its product line with complementary offerings. The company’s dedication to innovation and market responsiveness positions it well for sustained growth in the pharmaceutical sector.
Medicamen Organics IPO Objectives:
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Funding of expenses proposed to be incurred towards Product registration in the international markets;
- Plant updation and increase in production capacity;
- Funding working capital requirements of our Company; and
- General Corporate Purposes.
Medicamen Organics IPO Review (Apply or Not)
- Apply
Medicamen Organics IPO Date & Price Band Details:
| IPO Open: | June 21, 2024 |
| IPO Close: | June 25, 2024 |
| IPO Size: | Approx ₹10.54 Crores, 3,100,000 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹32 to ₹34 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 35% of the net offer |
| QIB Quota: | 50% of the net offer |
| NII Quota: | 15% of the net offer |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors in IPO: | Click Here |
Medicamen Organics IPO Lot Size:
The minimum market lot for the Medicamen Organics IPO consists of 4000 shares, requiring an application amount of ₹136,000. This structure ensures that investors can participate in the IPO with a defined unit of shares, facilitating broader participation in the offering.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 4000 | ₹136,000 |
| Retail Maximum | 1 | 4000 | ₹136,000 |
| S-HNI Minimum | 2 | 8000 | ₹272,000 |
Medicamen Organics IPO Timeline:
The Medicamen Organics IPO is scheduled to open on June 21 and will close on June 25. The IPO allotment date is set for June 26, with potential listing on June 28. This timeline outlines the key dates for investors interested in participating in the IPO process.
| IPO Open Date: | June 21, 2024 |
| IPO Close Date: | June 25, 2024 |
| Basis of Allotment: | June 26, 2024 |
| Refunds: | June 27, 2024 |
| Credit to Demat Account: | June 27, 2024 |
| IPO Listing Date: | June 28, 2024 |
Medicamen Organics IPO GMP Today:
The Grey Market Premium (GMP) for the Medicamen Organics SME IPO is ₹60. Given the IPO’s price band of ₹32 to ₹34, the estimated listing price is anticipated to be around ₹94 per share (₹34 + ₹60 GMP). This implies an expected percentage gain of approximately 176.47% per share upon listing. Investors and stakeholders can use this information to gauge potential market interest and initial valuation trends for Medicamen Organics post-listing.
Medicamen Organics Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹25.06 | ₹24.57 | ₹0.30 |
| 2022 | ₹21.19 | ₹20.93 | ₹0.09 |
| 2023 | ₹22.96 | ₹21.60 | ₹0.96 |
| September 2023 | ₹11.33 | ₹9.57 | ₹1.29 |
Medicamen Organics IPO Valuation – FY2023
Check Medicamen Organics IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹1.60 per Equity Share |
| Price/Earning P/E Ratio: | [.] |
| Return on Net Worth (RoNW): | 11.25% |
| Net Asset Value (NAV): | ₹14.20 per Equity Share |
Peer Group
- Brooks Laboratories Ltd
- Cian Healthcare Ltd
- Zenotech Laboratories Ltd
Company Promoters
- Mr. Bal Kishan Gupta
Medicamen Organics IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: medicamen.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Medicamen Organics IPO Allotment Status
Check Medicamen Organics IPO allotment status on Kfintech website URL. Click Here
Medicamen Organics IPO Lead Managers aka Merchant Bankers
- GYR Capital Advisors Private Limited
Company Address
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: cs@mediorganics.in
Website: http://www.medicamenorganics.com/
Medicamen Organics IPO FAQs
- What is the IPO date for Medicamen Organics?
- The Medicamen Organics IPO opens on June 21 and closes on June 25, 2024.
- What is the price band for Medicamen Organics IPO?
- The price band for Medicamen Organics IPO is set at ₹32 to ₹34 per share.
- What is the minimum market lot for the Medicamen Organics IPO?
- The minimum market lot for the Medicamen Organics IPO is 4000 shares.
- How much is the application amount for one market lot in Medicamen Organics IPO?
- For one market lot (4000 shares), the application amount is ₹136,000.
- When is the allotment date for Medicamen Organics IPO?
- The allotment date for the Medicamen Organics IPO is scheduled for June 26, 2024.
- When is the expected listing date of Medicamen Organics IPO?
- The expected listing date for Medicamen Organics IPO is June 28, 2024.
- What is the Grey Market Premium (GMP) for Medicamen Organics IPO?
- As of June 17, 2024, the Grey Market Premium (GMP) for Medicamen Organics IPO is ₹60.
- What is the estimated listing price of Medicamen Organics IPO considering the GMP?
- With a price band of ₹34 and a GMP of ₹60, the estimated listing price of Medicamen Organics IPO could be around ₹94 per share.
- What is the expected percentage gain per share upon listing for Medicamen Organics IPO?
- The expected percentage gain per share upon listing for Medicamen Organics IPO is approximately 176.47%.
